12/16
08:06 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
12/12
10:42 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at Guggenheim.
12/12
10:42 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "neutral" rating re-affirmed by analysts at Guggenheim.
12/12
10:35 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
12/12
10:35 am
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
12/11
12:27 pm
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
12/11
12:27 pm
sprb
Rating for SPRB
Medium
Report
Rating for SPRB
12/11
11:12 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1.50 price target on the stock, down previously from $2.00.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1.50 price target on the stock, down previously from $2.00.
12/11
11:12 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1.50 price target on the stock, down previously from $2.00.
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1.50 price target on the stock, down previously from $2.00.
12/11
10:54 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
12/11
10:54 am
sprb
Rating for SPRB
High
Report
Rating for SPRB
12/11
09:04 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at JMP Securities.
Low
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at JMP Securities.
12/11
09:04 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at JMP Securities.
Low
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at JMP Securities.
12/11
08:21 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
Medium
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
12/11
06:02 am
sprb
Rating for SPRB
Low
Report
Rating for SPRB
12/11
06:02 am
sprb
Rating for SPRB
Low
Report
Rating for SPRB
12/11
05:43 am
sprb
Spruce Biosciences downgraded to Perform from Outperform at Oppenheimer
Low
Report
Spruce Biosciences downgraded to Perform from Outperform at Oppenheimer
12/11
05:43 am
sprb
Spruce Biosciences downgraded to Perform from Outperform at Oppenheimer
Low
Report
Spruce Biosciences downgraded to Perform from Outperform at Oppenheimer
11/12
10:45 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
Low
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
11/12
10:45 am
sprb
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
Low
Report
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
11/12
09:54 am
sprb
Rating for SPRB
Low
Report
Rating for SPRB
11/12
09:54 am
sprb
Rating for SPRB
Low
Report
Rating for SPRB